Experienced in Transient Ischemic Attack (TIA)

Markus P. Schlaich

Level 3 MRF Building, Rear 50 Murray St, 
Perth, WA, AU 
Experienced in Transient Ischemic Attack (TIA)
Level 3 MRF Building, Rear 50 Murray St, 
Perth, WA, AU 
OverviewLocationsClinical Research

Overview

Markus Schlaich practices in Perth, Australia. Mr. Schlaich is rated as an Experienced expert by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Hypertension, Renovascular Hypertension, Obesity, Cardiac Ablation, and Heart Bypass Surgery.

His clinical research consists of co-authoring 429 peer reviewed articles and participating in 6 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Transient Ischemic Attack (TIA).

Gender
Male

Locations

Level 3 MRF Building, Rear 50 Murray St, Perth, WA 6000, Australia
Other Locations
197 Wellington St, Perth, WA 6000, Australia
75 Commercial Road, Melbourne, VIC 3004, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Global Clinical Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System in Patients With Uncontrolled Hypertension on Standard Medical Therapy (SPYRAL HTN-ON MED)
Enrollment Status: Active_not_recruiting
Publish Date: June 17, 2025
Intervention Type: Device, Procedure
Study Phase: Not Applicable
Sympathetic Nervous System Inhibition for the Treatment of Diabetic Nephropathy
Sympathetic Nervous System Inhibition for the Treatment of Diabetic Nephropathy
Enrollment Status: Completed
Publish Date: September 14, 2023
Intervention Type: Drug
Study Drug: Moxonidine
Study Phase: Phase 4
Interactions Between The Serotonin Transporter And Sympathetic Nervous System Activation In Patients With Major Depressive Disorder - Understanding The Link Between The Brain And The Heart
Interactions Between The Serotonin Transporter And Sympathetic Nervous System Activation In Patients With Major Depressive Disorder - Understanding The Link Between The Brain And The Heart
Enrollment Status: Completed
Publish Date: September 14, 2023
Intervention Type: Drug
Study Drug: Selective Serotonin Re-Uptake Inhibitor (SSRI) Antidepressant
Study Phase: Phase 4
A Randomised Trial Examining the Effectiveness of Sympathetic Nervous Inhibition in Alleviating the Metabolic Side Effects of Antipsychotic Medications in Patients With Schizophrenia
A Randomised Trial Examining the Effectiveness of Sympathetic Nervous Inhibition in Alleviating the Metabolic Side Effects of Antipsychotic Medications in Patients With Schizophrenia
Enrollment Status: Withdrawn
Publish Date: April 24, 2019
Intervention Type: Drug
Study Phase: Phase 4
Reveal LINQ™ Evaluation of Fluid
Reveal LINQ™ Evaluation of Fluid
Enrollment Status: Terminated
Publish Date: April 05, 2019
Intervention Type: Device
Study Phase: Not Applicable
First-In-Human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects With Treatment-Resistant Hypertension: A Safety and Feasibility Study
First-In-Human Study for Ultrasound Based Endovascular Carotid Body Ablation in Subjects With Treatment-Resistant Hypertension: A Safety and Feasibility Study
Enrollment Status: Unknown
Publish Date: April 10, 2018
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

429 Total Publications

May Measurement Month 2022: results of blood pressure screening in 30 countries.
May Measurement Month 2022: results of blood pressure screening in 30 countries.
Journal: European heart journal supplements : journal of the European Society of Cardiology
Published: September 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Schlaich's expertise for a condition
ConditionClose
View All 7 Advanced Conditions
View All 36 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile